International nonproprietary name: difference between revisions
Diff·revision 4 → 5·14:11, 18 Nov 2024
Difference between revision 4 and revision 5 of International nonproprietary name. 2 lines changed; the page grew by 230 bytes.
| Revision 4 — 23:20, 1 Nov 2024 StubSorterBot (talk) bot: normalise citation format 1,833 bytes ±0 | Revision 5 — 14:11, 18 Nov 2024 SeeAlsoSelma (talk) attribute the mechanism claim to the review rather than stating it flatly 2,063 bytes +230 | ||
|---|---|---|---|
| 11 | INNs are constructed from a distinctive prefix, chosen to be pronounceable and unlike existing names, and a stem indicating pharmacological class. The stem is the informative part: '''-glutide''' denotes a GLP-1 analogue, and '''-tide''' more broadly denotes a peptide.{{r|who_inn}} | 11 | INNs are constructed from a distinctive prefix, chosen to be pronounceable and unlike existing names, and a stem indicating pharmacological class. The stem is the informative part: '''-glutide''' denotes a GLP-1 analogue, and '''-tide''' more broadly denotes a peptide.{{r|who_inn}} |
| 12 | 12 | ||
| + | 13 | The name of a substance is therefore not arbitrary. ''Semaglutide'', ''liraglutide'', ''dulaglutide'' and ''tirzepatide'' all carry information about what kind of molecule they are, which is the point of the system.{{r|who_inn}} | |
| + | 14 | ||
| 13 | == Stems relevant here == | 15 | == Stems relevant here == |
| 14 | | Stem | Meaning | Examples | | 16 | | Stem | Meaning | Examples | |